Exchange: NASDAQ·Updated 07:33 PM EDT
CNTA logo

CNTA Centessa Pharmaceuticals PLC - ADR

$40.68
$0.32
(0.80%)
Today
Closed $40.50
$0.1835
(0.45%)
After Hours
Reported EarningsNov 5
Mkt Cap$6.27B
Vol11.33M

About CNTA

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
50

Neutral Sentiment

How do you feel about CNTA?

Advertisement|Remove ads.